Centessa Pharmaceuticals (STU:260) Tax Rate % : -1.28% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Centessa Pharmaceuticals Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Centessa Pharmaceuticals's Tax Expense for the three months ended in Mar. 2024 was €0.44 Mil. Centessa Pharmaceuticals's Pre-Tax Income for the three months ended in Mar. 2024 was €-34.56 Mil. Therefore, Centessa Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2024 was -1.28%.

Centessa Pharmaceuticals Tax Rate % Historical Data

The historical data trend for Centessa Pharmaceuticals's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Centessa Pharmaceuticals Tax Rate % Chart

Centessa Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

0.34

14.22

Centessa Pharmaceuticals Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Rate %	Get a 7-Day Free Trial										-1.35	49.15	6.81	-3.21	-1.28

Centessa Pharmaceuticals Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Centessa Pharmaceuticals's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	-22.976	/	-161.521
	=	14.22 %

Centessa Pharmaceuticals's Tax Rate % for the quarter that ended in Mar. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2024 )	/	Pre-Tax Income (Q: Mar. 2024 )
	=	0.443	/	-34.56
	=	-1.28 %

Centessa Pharmaceuticals Tax Rate % Related Terms

Thank you for viewing the detailed overview of Centessa Pharmaceuticals's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Centessa Pharmaceuticals (STU:260) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Centessa Pharmaceuticals PLC (STU:260) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

CNTA:USA

Address

1 Ashley Road, 3rd Floor, Altrincham, Cheshire, GBR, WA14 2DT

Website

https://www.centessa.com

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Centessa Pharmaceuticals (STU:260) Headlines

No Headlines